What is pancreatic cancer?
Pancreatic cancer occurs when cells in the pancreas—a gland behind the stomach that produces digestive enzymes and insulin—begin growing abnormally. It is often detected late because early symptoms are vague or absent.

Consult our curated network of highly qualified cancer specialists trained at AIIMS (New Delhi), Tata Memorial Centre (Mumbai), Rajiv Gandhi Cancer Institute, and other leading oncology centers.
Our specialists hold advanced qualifications including MD, DM, and M.Ch. degrees.

Consult our curated network of highly qualified cancer specialists trained at AIIMS (New Delhi), Tata Memorial Centre (Mumbai), Rajiv Gandhi Cancer Institute, and other leading oncology centers.
Our specialists hold advanced qualifications including MD, DM, and M.Ch. degrees.
Book Appointment with best doctors for Pancreatic Cancer in Delhi & get priority at the hospital through BigOHealth
Get treatment from best oncologists in Delhi for pancreatic cancer in top hospitals. Book appointment through BigOHealth and get assisted care & priority at the hospital.
We have doctors from top institutions at these hospitals for pancreatic cancer treatment in Delhi. The hospital names and addresses below are for reference, and appointments can be booked through BigOHealth for priority scheduling. These are among the best cancer treatment hospitals in India list that our oncologists are affiliated with.

Sector 44, Near HUDA City Centre Metro Station, Gurugram, Haryana 122003

1, Press Enclave Road, Saket Institutional Area, Saket, New Delhi, Delhi 110017

A-4, Paschim Vihar, New Delhi, Delhi 110063

Sector 128, Noida-Greater Noida Expressway, Noida, Uttar Pradesh 201304

Fortis Hospital, Sector B, Pocket 1, Aruna Asaf Ali Marg, Vasant Kunj, New Delhi, Delhi 110070
Hospital names and addresses are listed below for your reference. Book an appointment through BigOHealth and get priority appointment and support throughout your care journey. *
Should I see a hpb surgeon / pancreatic surgeon or gi medical oncologist or interventional radiologist / gastroenterologist? Here's who to consult first.
| HPB Surgeon / Pancreatic Surgeon | GI Medical Oncologist | Interventional Radiologist / Gastroenterologist | |
|---|---|---|---|
| Primary Role | Performs Whipple procedure, distal pancreatectomy, and complex pancreatic surgeries | Manages chemotherapy (FOLFIRINOX, Gem-Abraxane) and targeted therapy | Performs biliary stenting (ERCP/PTCD) for jaundice relief |
| When to Visit | First Step: If diagnosed with pancreatic mass and potentially resectable disease | Second Step: For neoadjuvant therapy, unresectable, or metastatic disease | Immediate: If presenting with obstructive jaundice before surgery/chemotherapy |
| Key Expertise | High-volume Whipple surgery, vascular reconstruction, minimally invasive techniques | Systemic therapy for pancreatic cancer, clinical trial access | Endoscopic procedures, biliary drainage, pain management interventions |
| Common Titles | HPB Surgeon, Pancreatic Surgeon, Surgical Oncologist | GI Oncologist, Medical Oncologist | Interventional Radiologist, Therapeutic Endoscopist |
Primary Role
Performs Whipple procedure, distal pancreatectomy, and complex pancreatic surgeries
When to Visit
First Step: If diagnosed with pancreatic mass and potentially resectable disease
Key Expertise
High-volume Whipple surgery, vascular reconstruction, minimally invasive techniques
Common Titles
HPB Surgeon, Pancreatic Surgeon, Surgical Oncologist
In Delhi, pancreatic cancer requires immediate multidisciplinary evaluation. Even 'resectable' tumors often receive neoadjuvant chemotherapy first. Start at a high-volume HPB center with integrated GI oncology—surgical expertise alone isn't enough. Get BRCA testing done early; it changes treatment strategy significantly.
Delhi has advanced technology for pancreatic cancer treatment. Ask your doctor if these facilities are available:
Hospitals performing 50+ Whipple procedures annually with <3% mortality rates. Expertise in vascular reconstruction and minimally invasive approaches.
24/7 availability of advanced endoscopy for metal stent placement, relieving jaundice within 48 hours and enabling chemotherapy initiation.
FOLFIRINOX and Gem-Abraxane regimens to downstage borderline resectable tumors, converting 30-40% to surgical candidates.
Rapid turnaround (7-10 days) for BRCA1/2, PALB2, and Lynch syndrome testing to guide platinum therapy and PARP inhibitor eligibility.
Precise, high-dose radiation in 5 sessions for locally advanced pancreatic cancer, improving local control and pain relief.
Celiac plexus neurolysis for intractable pancreatic cancer pain, providing 3-6 months pain relief in single session.
Dedicated GI palliative care teams managing pain, nutrition, biliary obstruction, and psychological support from diagnosis.
Participation in immunotherapy, novel chemotherapy, and targeted therapy trials for advanced pancreatic cancer.
When booking your pancreatic cancer consultation, ask the hospital coordinator if these technologies are available at their Delhi facility. Not all hospitals have the same level of infrastructure.
What should I ask my pancreatic cancer doctor? Here are 5 important questions for your first consultation:
Why it matters: Resectability status determines treatment strategy—upfront surgery vs neoadjuvant chemotherapy vs palliative intent. This is the most critical initial assessment.
Why it matters: Many centers now give chemotherapy first even for resectable tumors to test tumor biology and improve outcomes. Ask about institutional protocol and evidence supporting the approach.
Why it matters: 5-10% of pancreatic cancers have BRCA/PALB2 mutations. This qualifies you for platinum-based chemotherapy and PARP inhibitors (Olaparib), improving survival. Testing should be done early, not after progression.
Why it matters: Elevated CA 19-9 (>1000) suggests aggressive disease. CA 19-9 decline during chemotherapy predicts response. However, 10% of people lack the enzyme to produce CA 19-9, so normal levels don't rule out cancer.
Why it matters: Metal stent placement should happen within 48-72 hours to prevent cholangitis, improve liver function, and allow chemotherapy to start. Delayed stenting increases complications.
Why it matters: FOLFIRINOX is more effective but toxic (requires good fitness). Gem-Abraxane is better tolerated. Your age, performance status, and comorbidities determine the choice.
Why it matters: Pancreatic cancer treatment is complex. Tumor board discussion ensures surgeons, oncologists, and radiologists agree on optimal treatment sequence and timing.
Why it matters: Surgeon volume directly impacts outcomes. High-volume surgeons (20+ Whipples/year) have 3% mortality vs 10-15% at low-volume centers. Don't hesitate to ask this question.
Why it matters: Post-pancreatectomy, you'll need lifelong pancreatic enzyme supplements and possibly insulin. Understanding this helps with nutritional planning and realistic expectations.
Why it matters: Early palliative care (starting at diagnosis) improves quality of life, reduces depression, and may extend survival. It's not just for end-of-life care—it supports you through treatment.
Our team helps you prepare a list of important questions to ask your doctor, so you can make the most of your consultation. Message us, and we'll be happy to assist you.
Bring all imaging (CT/MRI on CD/USB), biopsy pathology report, CA 19-9 blood test, liver function tests, and list of all medications. Pancreatic cancer moves fast—get second opinion quickly (within 1 week) if considering major surgery. Time is critical.
Selecting the right pancreatic cancer specialist can significantly impact your treatment journey. Here are 10 important factors to help you evaluate doctors and hospitals with confidence.
Choose an HPB surgeon performing 20+ Whipple procedures annually. High-volume centers achieve perioperative mortality <3% vs 10-15% at low-volume centers. Ask about pancreatic leak rates (<10% is acceptable), delayed gastric emptying management, and median hospital stay (12-14 days).
Confirm weekly tumor boards including HPB surgeons, GI oncologists, radiation oncologists, interventional radiologists, and pathologists. Borderline resectable cases require consensus on neoadjuvant therapy vs upfront surgery. MDT approach improves resection rates by 20-30%.
For borderline resectable tumors, verify hospital follows neoadjuvant FOLFIRINOX or Gem-Abraxane protocols. Ask about restaging imaging timeline (after 2-4 cycles) and CA 19-9 monitoring. 25-40% of borderline cases become resectable after neoadjuvant therapy.
Ensure 24/7 therapeutic endoscopy for urgent biliary decompression. Jaundiced patients require stenting within 48-72 hours to prevent cholangitis and enable chemotherapy. Ask about metal vs plastic stent preference (metal stents last 6-12 months vs 3 months for plastic).
For all pancreatic cancer patients (not just family history), verify BRCA1/2, PALB2, and Lynch syndrome testing within 2 weeks. 5-10% have germline mutations qualifying for platinum-based chemotherapy and PARP inhibitors (Olaparib), improving survival by 6-12 months.
Ask about hospital's preferred first-line regimen. FOLFIRINOX offers better response (32% vs 23%) but higher toxicity, requiring good performance status. Gem-Abraxane is better tolerated in older/frail patients. Verify availability of growth factors (G-CSF) to manage neutropenia.
Look for hospitals initiating palliative care consultation at diagnosis (not just end-stage). Early palliative care improves quality of life scores by 40%, reduces depression, and may extend survival by 2-3 months. Ask about dedicated GI palliative care team availability.
Post-pancreatectomy or for locally advanced disease, confirm availability of pancreatic enzyme supplements (Creon, Pancreatin) with insurance coverage. Proper enzyme dosing (50,000-75,000 lipase units per meal) prevents malabsorption and weight loss, improving treatment tolerance.
For metastatic/recurrent pancreatic cancer, verify participation in immunotherapy trials (checkpoint inhibitors for MSI-high, vaccine trials), novel chemotherapy combinations, or targeted therapy studies. Trial access can provide treatments 2-3 years before commercial availability.
Confirm availability of interventional pain specialists offering celiac plexus neurolysis for intractable pancreatic cancer pain. Single-session nerve block provides pain relief for 3-6 months in 70-80% of patients, reducing opioid requirements and improving quality of life.
During your pancreatic cancer consultation in Delhi, ask your doctor about each of these factors. These questions help you identify truly experienced specialists and well-equipped hospitals for the best pancreatic cancer treatment outcomes.



Need help deciding best doctor for Pancreatic Cancer
Our care team is here for you.
At BigOHealth, we provide transparent cost breakdowns that include surgery, chemotherapy, and advanced targeted therapies. By choosing a specialized Pancreatic Cancer oncologists in Delhi, you can reduce out-of-pocket expenses while maintaining international standards of care. Costs are indicative and vary based on resectability, surgical complications, chemotherapy regimen choice, hospital infrastructure, and intensive supportive care needs.*
N/A
Disclaimer: Indicative estimates only. Individual plans depend on clinical staging, biology & personalization.
Real experiences from Indian patients & caregivers navigating multidisciplinary cancer care.
Coordinated care, clear cost guidance and compassionate follow‑ups made a tough journey feel structured and hopeful.
Streamlined appointments, quick second opinions and transparent estimates reduced our anxiety significantly.
Streamlined appointments, quick second opinions and transparent estimates reduced our anxiety significantly.
Nutritional guidance & rehabilitation tracking helped me recover strength faster after completing therapy.
Nutritional guidance & rehabilitation tracking helped me recover strength faster after completing therapy.
Cost breakdowns were precise; I could plan insurance claims and avoid surprise expenses.
Cost breakdowns were precise; I could plan insurance claims and avoid surprise expenses.
Doctor selection filters saved time. Remote updates kept extended family informed without chaos.
Doctor selection filters saved time. Remote updates kept extended family informed without chaos.
Personalized staging explanation and therapy pathway boosted my confidence before starting cycles.
Personalized staging explanation and therapy pathway boosted my confidence before starting cycles.
Coordinated care, clear cost guidance and compassionate follow‑ups made a tough journey feel structured and hopeful.
Real work. Real impact. Embedded education & innovation content—watch videos, explore research, and see how BigOHealth advances cancer care.
Unified, compact view of symptom clusters and treatment impact. Content remains fully visible for search engines; search gently highlights matching terminology.
Early, common & advanced signs of pancreatic cancer

Short & long-term side effects of pancreatic cancer treatment
Informational reference only; seek urgent care for severe or rapidly worsening symptoms.
Get your Pancreatic Cancer systematically reviewed through a multidisciplinary tumor board, where surgical, medical, and radiation oncologists collectively evaluate reports, imaging, and pathology to support evidence-based treatment planning personalised for you.
Clear, patient‑friendly answers to common pancreatic cancer queries. All FAQs are visible (no accordion) for easy scanning and search optimization.
Pancreatic cancer occurs when cells in the pancreas—a gland behind the stomach that produces digestive enzymes and insulin—begin growing abnormally. It is often detected late because early symptoms are vague or absent.
Common symptoms include jaundice (yellowing of skin and eyes), upper abdominal or back pain, unexplained weight loss, loss of appetite, nausea, and new-onset diabetes. Symptoms usually appear when the cancer is already advanced.
Pancreatic cancer develops due to genetic mutations that cause pancreatic cells to grow uncontrollably. Risk factors include smoking, obesity, chronic pancreatitis, diabetes, family history, and age over 60. Many cases have no clear cause.
Pancreatic cancer is hard to cure because it's often found late. However, if detected early and the tumor is removable, surgery combined with chemotherapy can be curative. Treatment focuses on extending life and managing symptoms in advanced cases.
Diagnosis involves imaging tests like CT scans, MRI, or endoscopic ultrasound to locate tumors. Blood tests (CA 19-9 marker) and biopsies help confirm the diagnosis. Early detection is challenging due to the pancreas's deep location.
Pancreatic cancer is deadly because it rarely shows symptoms until it has spread to other organs. The pancreas is also located deep in the body, making early detection difficult. By the time it's found, treatment options are often limited.
India's best cancer hospitals for treatment include AIIMS Cancer Institute New Delhi (All India Institute of Medical Sciences), Tata Memorial Hospital Mumbai — the top cancer treatment hospital in India for volume and research — Rajiv Gandhi Cancer Institute & Research Centre (RGCI) Delhi, Adyar Cancer Institute Chennai, and Cancer Institute (WIA) Chennai. Tata Memorial Hospital Mumbai is widely regarded as the best cancer hospital in Mumbai and one of the finest in Asia for top cancer care. BigOHealth connects patients seeking second opinions from or alternatives to these top cancer hospitals in India with verified oncologists for consultations and tumor board reviews online.
Educational guidance only; consult qualified oncology professionals for personalized medical advice.



Need help deciding best doctor for Pancreatic Cancer
Our care team is here for you.